Brief: Synthaverse Signs License Deal For Davoster Medical Product
16/05/2024 17:21
May 16 (Reuters) - Synthaverse SA SVEP.WA :
* SIGNS LICENSE DEAL WITH SWISS BASED PHARMACEUTICAL COMPANY
CHEMO
* DEAL REGARDS LICENCE FOR DAVOSTER MEDICAL PRODUCT
* FIRST PROCEEDINGS FOR LICENSE DEAL TO BE ACCOUNTED IN Q4
FINANCIAL REPORT
* DEAL SIGNED FOR 5-YEAR PERIOD
Source text for Eikon: ID:nEM3RgXdta
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility